Patents by Inventor Brent O'BRIEN

Brent O'BRIEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981900
    Abstract: This disclosure provides methods and compositions for increasing genome editing and site-directed integration events utilizing guided endonucleases and meiotic cell-preferred, egg cell-preferred or embryo tissue-preferred promoters.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: May 14, 2024
    Assignee: Monsanto Technology LLC
    Inventors: Matthew J. Bauer, Lisa Kanizay, Jonathan Lamb, Matthew S. Marengo, Brent O'Brien
  • Publication number: 20240117369
    Abstract: This disclosure provides methods and compositions for increasing genome editing and site-directed integration events utilizing guided endonucleases and floral cell-preferred or floral tissue-preferred promoters.
    Type: Application
    Filed: March 28, 2023
    Publication date: April 11, 2024
    Applicant: Monsanto Technology LLC
    Inventors: Matthew Bauer, Brent Delbert Brower-Toland, Shunhong Dai, Brent O'Brien, Thomas L. Slewinski
  • Publication number: 20240108265
    Abstract: The present disclosure generally relates to methods and systems for generating a void profile for user void events. The method includes receiving by a processing element a plurality of outputs from a fluid level sensor corresponding to a plurality of levels of fluid flowing through a voiding device during a flow event; determining by the processing element a beginning and an end time of the fluid flow into the voiding device during the flow event; analyzing the plurality of outputs of the fluid level sensor over a time interval defined by the beginning and end time of the fluid flow to determine at least one of a fluid flow rate data and an accumulated volume data for the fluid flowing through the voiding device; and storing the fluid flow rate data and the accumulated flow volume data in a memory.
    Type: Application
    Filed: September 11, 2023
    Publication date: April 4, 2024
    Inventors: Brent Laing, John Green, Paul R. Johnson, Robert John Smith, Robert Edwin Schneider, Magnus Hargis, Elise Geolat Edson, Elizabeth A. O'Brien
  • Patent number: 11932863
    Abstract: The invention provides recombinant DNA molecules and constructs, as well as their nucleotide sequences, useful for modulating gene expression in plants. The invention also provides transgenic plants, plant cells, plant parts, and seeds comprising the recombinant DNA molecules operably linked to heterologous transcribable DNA molecules, as are methods of their use.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: March 19, 2024
    Assignee: Monsanto Technology LLC
    Inventors: Charles L Armstrong, Andrei Y. Kouranov, Brent A. O'Brien
  • Patent number: 11925465
    Abstract: Uroflowmeters and methods for processing data generated therefrom are disclosed. In one aspect, the uroflowmeter is a handheld device. The uroflowmeter includes a handle, a flow chamber coupled to the handle, and a sensor associated with the flow chamber that detects a parameter of urine received in the flow chamber. The uroflowmeter may include both reusable and disposable components. As a uroflowmeter it can identify and record data corresponding to the rate of flow over the measured duration of a void of urine, but may also timestamp the voiding act and communicate the data to an external data collection center for additional analysis and incorporation into a comprehensive voiding report or voiding diary.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 12, 2024
    Assignee: ClearTrac Technologies, LLC
    Inventors: Brent Laing, John Green, Paul R. Johnson, Robert John Smith, Robert Edwin Schneider, Magnus Hargis, Elise Geolat Edson, Elizabeth A. O'Brien, Joseph L. Kapushion
  • Publication number: 20220403401
    Abstract: The invention provides compositions and methods useful for modulating protein expression in eukaryotic cells. The invention also provides transgenic plants, edited plant cells, plant parts, and seeds comprising depleted or optimized Kozak sequences and methods of their use.
    Type: Application
    Filed: June 9, 2022
    Publication date: December 22, 2022
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Keith DECKER, Bryan GONTAREK, Natalia IVLEVA, Hong LI, Matthew MARENGO, Ervin NAGY, Brent O'Brien, Qungang QI, Graziana TARAMINO
  • Publication number: 20220073937
    Abstract: This disclosure provides methods and compositions for increasing genome editing and site-directed integration events utilizing guided endonucleases and meiotic cell-preferred, egg cell-preferred or embryo tissue-preferred promoters.
    Type: Application
    Filed: September 9, 2021
    Publication date: March 10, 2022
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Matthew J. BAUER, Lisa KANIZAY, Jonathan LAMB, Matthew S. MARENGO, Brent O'BRIEN
  • Publication number: 20210238616
    Abstract: The invention provides recombinant DNA molecules and constructs, as well as their nucleotide sequences, useful for modulating gene expression in plants. The invention also provides transgenic plants, plant cells, plant parts, and seeds comprising the recombinant DNA molecules operably linked to heterologous transcribable DNA molecules, as are methods of their use.
    Type: Application
    Filed: January 11, 2021
    Publication date: August 5, 2021
    Inventors: Charles L. Armstrong, Andrei Y. Kouranov, Brent A. O'Brien